Forte Biosciences, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
PEPG
PepGen Inc. |
$5.66 | $402.80 M | -2.08 | 79 |
NKTX
Nkarta, Inc. |
$1.88 | $133.89 M | -1.37 | 157 |
MOLN
Molecular Partners AG |
$4.33 | $160.05 M | -2.12 | 158 |
FATE
Fate Therapeutics, Inc. |
$1.15 | $126.28 M | -0.82 | 181 |
ELTX
Elicio Therapeutics, Inc. |
$8.19 | $139.62 M | -2.6 | 32 |
CRDF
Cardiff Oncology, Inc. |
$2.39 | $164.94 M | -3.1 | 32 |
CRBP
Corbus Pharmaceuticals Holdings, Inc. |
$9.70 | $128.61 M | -1.87 | 28 |
APLT
Applied Therapeutics, Inc. |
$0.12 | $16.90 M | -1.17 | 35 |
ALEC
Alector, Inc. |
$1.49 | $149.82 M | -1.41 | 175 |
ACTU
Actuate Therapeutics Inc |
$7.52 | $175.72 M | 22.24 | 10 |